StonvexLoading…
StonvexStonvexStonvexCore line items from ICL's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $7.15B | $6.84B | $7.54B | $10.02B |
Operating Income | $580.00M | $775.00M | $1.14B | $3.52B |
Net Income | $280.00M | $464.00M | $687.00M | $2.22B |
EPS (Diluted) | $0.18 | $0.32 | $0.50 | $1.67 |
Total Assets | $12.41B | $11.32B | $11.63B | $11.75B |
Total Liabilities | $6.17B | $5.33B | $5.59B | $6.04B |
Cash & Equivalents | $291.00M | $327.00M | $420.00M | $417.00M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | Not available | Not available | Not available |